Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CDN1163 is a small molecule activator of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 38.00 | |
5 mg | In stock | $ 61.00 | |
10 mg | In stock | $ 89.00 | |
25 mg | In stock | $ 166.00 | |
50 mg | In stock | $ 296.00 | |
100 mg | In stock | $ 522.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 68.00 |
Description | CDN1163 is a small molecule activator of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA). |
In vivo | CDN1163, which markedly lowered fasting blood glucose, improved glucose tolerance, and ameliorated hepatosteatosis but did not alter glucose levels or body weight in lean controls.?Importantly, CDN1163-treated ob/ob mice maintained euglycemia comparable with that of lean mice for >6 weeks after cessation of CDN1163 administration[1]. |
Molecular Weight | 320.39 |
Formula | C20H20N2O2 |
CAS No. | 892711-75-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (156.06 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CDN1163 892711-75-0 Membrane transporter/Ion channel Metabolism Calcium Channel Inhibitor Ca channels Ca2+ channels CDN-1163 CDN 1163 inhibit inhibitor